CD24 and neoplasm: Interestingly, combining the status of CD24 expression in tumor cells with the density of CD3+ tumor-infiltrating lymphocytes (TIL), a microenvironment/immune-related marker, identified a high-risk subgroup with the worst DFS and OS.